#151441

Anti-Keratin14 [LL002]

Cat. #151441

Anti-Keratin14 [LL002]

Cat. #: 151441

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Keratin 14

Class: Monoclonal

Application: FACS ; IHC ; IF ; WB

Reactivity: Human ; Mouse ; Pig

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Birgit Lane

Institute: Queen Mary University of London

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Keratin14 [LL002]
  • Research fields: Cell signaling and signal transduction
  • Clone: LL002
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 50 kDa
  • Strain: Balb/c
  • Reactivity: Human ; Mouse ; Pig
  • Host: Mouse
  • Application: FACS ; IHC ; IF ; WB
  • Description: Monoclonal antibody directed keratin 14, with use in identifying squamous cell carcinoma, and distinguishing basal breast carcinomas.
  • Immunogen: The last 16 carboxy-terminal amino acids of human keratin, in the form of a synthetic peptide. This was coupled to thyroglobulin by the extra Cys added at the N terminus.
  • Immunogen uniprot id: P02533
  • Isotype: IgG3
  • Myeloma used: Sp2/0-Ag14

Target Details

  • Target: Keratin 14
  • Molecular weight: 50 kDa
  • Target background: Monoclonal antibody directed keratin 14, with use in identifying squamous cell carcinoma, and distinguishing basal breast carcinomas.

Applications

  • Application: FACS ; IHC ; IF ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: Store at -20° C frozen. Avoid repeated freeze / thaw cycles
  • Shipping conditions: Shipping at 4° C

References

  • Hagiyama et al. 2017. Front Physiol. 8:997. PMID: 29259558.
  • Kuga et al. 2016. Sci Rep. 6:26557. PMID: 27222304.
  • Haikala et al. 2016. Cell Cycle. 15(3):316-23. PMID: 26873145.
  • Bohn et al. 2010. Int J Clin Exp Pathol. 3(6):600-7. PMID: 20661408.
  • p16INK4a expression in basal-like breast carcinoma.
  • Kurzrock et al. 2008. Am J Physiol Renal Physiol. 294(6):F1415-21. PMID: 18367656.
  • Label-retaining cells of the bladder: candidate urothelial stem cells.
  • Purkis et al. 1990. J Cell Sci. 97 ( Pt 1):39-50. PMID: 1701769.
  • Antibody markers of basal cells in complex epithelia.
  • Schaafsma et al. 1990. Am J Pathol. 136(2):329-43. PMID: 1689541.
  • Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression.